Search Results 1421-1430 of 16234 for alt

1. A Study Evaluating Pembrolizumab and Epacadostat in Treating Participants With Recurrent, Persistent, or Progressive Ovarian Clear Cell Carcinoma - Mayo Clinic

   Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< 2.5 x ULN within 14 days prior to registration. Normal thyroid function testing ...

2. A Study Of CTX-712 In Relapsed/Refractory Acute Myeloid Leukemia And Higher Risk Myelodysplastic Syndromes - Mayo Clinic

   Alanine aminotransferase (ALT) ;. Aspartate aminotransferase(AST) < 2.5 × ULN;. White blood cell count at the time of the first dose < 10 k/µL. Eastern ...

3. Sapanisertib in Treating Patients With Relapsed and/or Refractory Acute Lymphoblastic Leukemia - Mayo Clinic

   ... (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 2.5 × institutional upper limit of normal; Creatinine =< 1.5 × institutional upper limit of normal ...

4. HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide - Mayo Clinic

   supplemental oxygen. 10. Hepatic: Total bilirubin ≤ 2.5 mg/dL and alanine aminotransferase (ALT), aspartate aminotransferase (AST) < 3x the upper limit of ...

5. A Study to Evaluate the Effects of N-Acetyl-L-Leucine for GM2 Gangliosdisosis (Tay-Sachs and Sandhoff Disease) - Mayo Clinic

   Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) >5x upper limit of normal (ULN);; Total bilirubin >1.5x ULN, unless Gilbert's syndrome is ...

6. Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma - Mayo Clinic

   * Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 3 × institutional ULN (within 28 days prior to registration) * Lactate dehydrogenase ...

7. Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™ - Mayo Clinic

   Participation eligibility · Hepatic: total bilirubin ≤1.5 times upper limit of normal (ULN); alanine transaminase (ALT) and aspartate transaminase (AST) ≤1.5 ...

8. A Study to Evaluate Aspirin for Treating Multiple Sclerosis-related Fatigue - Mayo Clinic

   Aspartate aminotransferase (AST/SGOT) or alanine aminotransferase (ALT/SGPT) level greater than 2.5 times the upper limit of normal. Participating Mayo ...

9. Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer - Mayo Clinic

   Alanine aminotransferase (ALT) and aspartate transaminase (AST) ≤ 3 x ULN. Ability to swallow oral medication. Provide written informed consent ...

10. Study Assessing Safety and Efficacy of Combination of BL-8040 and Pembrolizumab in Metastatic Pancreatic Cancer Patients (COMBAT/KEYNOTE-202) - Mayo Clinic

    AST (SGOT) and ALT (SGPT): ≤2.5xULN OR ≤5xULN for subjects with liver metastases. Coagulation: INR or PT: ≤1.5xULN unless subject is receiving ...